Agilent Receives FDA Approval for Colorectal Cancer Companion Diagnostic
The MMR IHC Panel pharmDx helps identify patients eligible for immunotherapy treatment with Bristol Myers Squibb’s Opdivo alone or in combination with Yervoy.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
